GLP-1 therapy is a medically guided treatment that may help regulate appetite, blood sugar, and weight
GIPR agonism supports glucose-dependent insulin release and lipid metabolism, while GCGR activation is linked to increased energy expenditure, hepatic lipolysis, and thermogenesis processes that together distinguish it from earlier incretin-based research compounds such as semaglutide and tirzepatide
The tirzepatide oral drops and tablet formulations are also expanding the delivery method options beyond injections
For example, our NMN + Trans-Resveratrol formula supports NAD+ levels, which are also vital for cellular energy and are depleted by alcohol
Flow Wellness will help you make sense of it
Clinical Investigation Stier et al